CHA
LLY icon

Carmichael Hill & Associates’s Eli Lilly LLY Stock Holding History

Carmichael Hill & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.67M Buy
3,013
+6
+0.2% +$5.39K 0.95% 25
2024
Q2 		$2.72M Sell
3,007
-5
-0.2% -$4K 1.07% 23
2024
Q1 		$2.34M Buy
3,012
+35
+1% +$24.9K 0.93% 28
2023
Q4 		$1.74M Sell
2,977
-50
-2% -$29.2K 0.72% 31
2023
Q3 		$1.63M Hold
3,027
– – 0.75% 30
2023
Q2 		$1.42M Sell
3,027
-3
-0.1% -$1.26K 0.63% 36
2023
Q1 		$1.04M Hold
3,030
– – 0.5% 49
2022
Q4 		$1.11M Hold
3,030
– – 0.57% 42
2022
Q3 		$980K Buy
3,030
+1
+0% +$317 0.53% 41
2022
Q2 		$982K Hold
3,029
– – 0.52% 43
2022
Q1 		$867K Buy
3,029
+50
+2% +$12.9K 0.4% 59
2021
Q4 		$823K Hold
2,979
– – 0.37% 55
2021
Q3 		$688K Hold
2,979
– – 0.34% 60
2021
Q2 		$684K Sell
2,979
-33
-1% -$6.63K 0.35% 62
2021
Q1 		$563K Buy
3,012
+45
+2% +$8.8K 0.31% 70
2020
Q4 		$501K Hold
2,967
– – 0.3% 75
2020
Q3 		$439K Hold
2,967
– – 0.29% 71
2020
Q2 		$487K Hold
2,967
– – 0.36% 61
2020
Q1 		$412K Hold
2,967
– – 0.36% 63
2019
Q4 		$390K Hold
2,967
– – 0.28% 76
2019
Q3 		$332K Buy
2,967
+36
+1% +$4.01K 0.33% 79
2019
Q2 		$325K Hold
2,931
– – 0.32% 79
2019
Q1 		$380K Sell
2,931
-45
-2% -$5.47K 0.39% 71
2018
Q4 		$344K Hold
2,976
– – 0.39% 74
2018
Q3 		$319K Hold
2,976
– – 0.31% 79
2018
Q2 		$254K Hold
2,976
– – 0.27% 92
2018
Q1 		$230K Hold
2,976
– – 0.25% 102
2017
Q4 		$251K Buy
+2,976
New +$253K 0.27% 97

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Carmichael Hill & Associates's LLY Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Eli Lilly (LLY) stake by 0.2% in Q3 2024, buying an estimated $5.39K and bringing the position to 3,013 shares worth $2.67M. The position accounts for 0.95% of the portfolio, ranked #25.

Carmichael Hill & Associates first reported a position in LLY in Q4 2017 and has held it in 28 quarters since. The position peaked at $2.72M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Carmichael Hill & Associates held 3,013 shares of Eli Lilly worth $2.67M as of Q3 2024.
  • Carmichael Hill & Associates bought 6 Eli Lilly shares in Q3 2024, an estimated $5.39K.
  • Eli Lilly made up 0.95% of Carmichael Hill & Associates's portfolio in Q3 2024, its #25 holding.
  • Carmichael Hill & Associates first reported a position in Eli Lilly in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Eli Lilly position peaked at $2.72M in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.